BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24165726)

  • 1. Linking the SWI/SNF complex to prostate cancer.
    Lee RS; Roberts CW
    Nat Genet; 2013 Nov; 45(11):1268-9. PubMed ID: 24165726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.
    Atala A
    J Urol; 2014 Aug; 192(2):613. PubMed ID: 25035039
    [No Abstract]   [Full Text] [Related]  

  • 3. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.
    Prensner JR; Iyer MK; Sahu A; Asangani IA; Cao Q; Patel L; Vergara IA; Davicioni E; Erho N; Ghadessi M; Jenkins RB; Triche TJ; Malik R; Bedenis R; McGregor N; Ma T; Chen W; Han S; Jing X; Cao X; Wang X; Chandler B; Yan W; Siddiqui J; Kunju LP; Dhanasekaran SM; Pienta KJ; Feng FY; Chinnaiyan AM
    Nat Genet; 2013 Nov; 45(11):1392-8. PubMed ID: 24076601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.
    Kim KH; Roberts CW
    Cancer Genet; 2014 Sep; 207(9):365-72. PubMed ID: 24853101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
    Wang X; Sansam CG; Thom CS; Metzger D; Evans JA; Nguyen PT; Roberts CW
    Cancer Res; 2009 Oct; 69(20):8094-101. PubMed ID: 19789351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler.
    Woodley CM; Romer AS; Wang J; Guarnaccia AD; Elion DL; Maxwell JN; Guerrazzi K; McCann TS; Popay TM; Matlock BK; Flaherty DK; Lorey SL; Liu Q; Tansey WP; Weissmiller AM
    Oncogene; 2021 May; 40(20):3593-3609. PubMed ID: 33931740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SWI/SNF remains localized to chromatin in the presence of SCHLAP1.
    Raab JR; Smith KN; Spear CC; Manner CJ; Calabrese JM; Magnuson T
    Nat Genet; 2019 Jan; 51(1):26-29. PubMed ID: 30510238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors.
    McKenna ES; Tamayo P; Cho YJ; Tillman EJ; Mora-Blanco EL; Sansam CG; Koellhoffer EC; Pomeroy SL; Roberts CW
    Cell Cycle; 2012 May; 11(10):1956-65. PubMed ID: 22544318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.
    Rao Q; Xia QY; Wang ZY; Li L; Shen Q; Shi SS; Wang X; Liu B; Wang YF; Shi QL; Ma HH; Lu ZF; He Y; Zhang RS; Yu B; Zhou XJ
    Histopathology; 2015 Jul; 67(1):121-9. PubMed ID: 25496315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex.
    Sen P; Luo J; Hada A; Hailu SG; Dechassa ML; Persinger J; Brahma S; Paul S; Ranish J; Bartholomew B
    Cell Rep; 2017 Feb; 18(9):2135-2147. PubMed ID: 28249160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAFfling pathologies: Alterations of BAF complexes in cancer.
    Arnaud O; Le Loarer F; Tirode F
    Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway.
    He L; Chen Y; Feng J; Sun W; Li S; Ou M; Tang L
    Int J Biochem Cell Biol; 2017 Sep; 90():29-37. PubMed ID: 28716547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters.
    Kuwahara Y; Wei D; Durand J; Weissman BE
    Mol Cancer Res; 2013 Mar; 11(3):251-60. PubMed ID: 23364536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development.
    Wei D; Goldfarb D; Song S; Cannon C; Yan F; Sakellariou-Thompson D; Emanuele M; Major MB; Weissman BE; Kuwahara Y
    Mol Cancer Res; 2014 Nov; 12(11):1574-85. PubMed ID: 25009291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SWI/SNF complex in cancer.
    Lu C; Allis CD
    Nat Genet; 2017 Jan; 49(2):178-179. PubMed ID: 28138149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWI/SNF chromatin remodeling and human malignancies.
    Masliah-Planchon J; Bièche I; Guinebretière JM; Bourdeaut F; Delattre O
    Annu Rev Pathol; 2015; 10():145-71. PubMed ID: 25387058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation.
    Gresh L; Bourachot B; Reimann A; Guigas B; Fiette L; Garbay S; Muchardt C; Hue L; Pontoglio M; Yaniv M; Klochendler-Yeivin A
    EMBO J; 2005 Sep; 24(18):3313-24. PubMed ID: 16138077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human SNF5/INI1, a component of the human SWI/SNF chromatin remodeling complex, promotes nucleotide excision repair by influencing ATM recruitment and downstream H2AX phosphorylation.
    Ray A; Mir SN; Wani G; Zhao Q; Battu A; Zhu Q; Wang QE; Wani AA
    Mol Cell Biol; 2009 Dec; 29(23):6206-19. PubMed ID: 19805520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights.
    Wang X; Haswell JR; Roberts CW
    Clin Cancer Res; 2014 Jan; 20(1):21-7. PubMed ID: 24122795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus.
    Kia SK; Gorski MM; Giannakopoulos S; Verrijzer CP
    Mol Cell Biol; 2008 May; 28(10):3457-64. PubMed ID: 18332116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.